Moderna’s mRNA cancer vaccine shows promise in early trial Subject :Science and Technology Context- A customized Moderna Inc. vaccine combined with a Merck & Co. cancer drug helped ward off the recurrence of the skin cancer melanoma after surgery in patients in a mid-stage clinical trial. Detail- A combination of the Moderna’s experimental […]